At a glance
| Chemical family | Alkane — industrial solvent (constituent of commercial hexane) |
| CAS number | 110-54-3 |
| Classification | Not classified as a carcinogen by IARC. Primary toxicological concern: peripheral neuropathy from chronic high exposure (metabolite 2,5-hexanedione) |
| Where you encounter it | Industrial adhesives, rubber cements, leather and shoe manufacturing, food-grade extraction (vegetable oils), gasoline component. May be residual in furniture adhesives |
| Sleep micro-environment relevance | Minor — may be residual from furniture adhesives and leather goods but dissipates quickly (highly volatile). Not a carcinogen. Neurotoxic only at sustained occupational exposures well above consumer levels |
Regulatory & certification status
| European Union | REACH registered. CLP Repr. 2 (H361f — suspected reproductive toxicity), STOT RE 1 (H372 — nerve damage). Occupational exposure limit: 20 ppm (8-hr TWA). Regulatory |
| United States | OSHA PEL: 500 ppm (TWA). NIOSH REL: 50 ppm (TWA). California Proposition 65 not listed for cancer (not a carcinogen). Regulatory |
| Canada | OEL: 50 ppm (TWA) in most provinces. Not listed under CEPA Schedule 1. Regulatory |
| International | Not IARC classified. WHO does not set indoor air quality guideline for n-hexane. ACGIH TLV: 50 ppm. Regulatory |
What it is
n-Hexane is the unbranched six-carbon alkane (C6H14). It is a major component of commercial hexane solvent, which is widely used in the adhesive, rubber, and extraction industries. IARC has not classified n-hexane as a carcinogen — there is no evidence of cancer risk. The toxicological concern with n-hexane is peripheral neuropathy: the liver metabolises n-hexane to 2,5-hexanedione, a gamma-diketone that cross-links neurofilament proteins and causes distal axonal neuropathy. This has been documented in occupational settings where workers were exposed to high concentrations over extended periods. At consumer-level exposures, n-hexane poses no significant risk.
Where it shows up in bedding
n-Hexane is not an ingredient in bedding. It may be present as a residual solvent from adhesives used in furniture assembly (particleboard headboards, nightstands), leather-upholstered bed frames, and some footwear stored in bedrooms. However, n-hexane is extremely volatile (boiling point 69°C) and dissipates rapidly from finished products. Any residual n-hexane from manufacturing would largely evaporate before reaching the consumer. New furniture or leather goods may release trace amounts initially, but levels decline to negligible within days.
The Embr Exposure Ledger: n-Hexane
One chemical, several public questions, answered from independent datasets and joined here — the environment it shows up in, the body burden it carries, how it is regulated, and what actually reduces it.
Detection and body-burden figures are occurrence data, not a personal measurement or a health diagnosis. Part of the Embr Exposure Ledger — an open, cross-dataset chemical join (download the data), reusable with attribution.
Citations
- ATSDR (1999). Toxicological Profile for n-Hexane. Source Regulatory
- EPA. n-Hexane — Hazard Summary. Source Regulatory
- WHO (2003). n-Hexane. Concise International Chemical Assessment Document 45. Source Regulatory
Frequently asked questions
Can n-hexane cause nerve damage from furniture off-gassing?
At the trace levels released by finished furniture, no. The peripheral neuropathy caused by n-hexane requires sustained high exposure (typically occupational concentrations of hundreds of ppm over weeks or months). Residual n-hexane from furniture adhesives dissipates rapidly and consumer exposure levels are orders of magnitude below the threshold for nerve damage.
Is n-hexane a carcinogen?
No. IARC has not classified n-hexane as a carcinogen, and there is no evidence of cancer risk from n-hexane exposure. Its primary health concern is peripheral neuropathy from chronic high occupational exposure, not cancer.
Related compounds
Embr is a sleep environment company researching and addressing the chemistry of the bedroom. Research and product development in progress.
Last reviewed 2026-07-07. If you find a factual error, contact us.
